Patent details

EP3106463 Title: PYRAZOLO[1,5-]PYRIMIDINE COMPOUND AS TRK KINASE INHIBITOR

Basic Information

Publication number:
EP3106463
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP161664610
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PYRAZOLO[1,5-]PYRIMIDINE COMPOUND AS TRK KINASE INHIBITOR
French Title of Invention:
PYRAZOLO [1,5-] PYRIMIDINE EN TANT QU'INHIBITEUR DE KINASES TRK
German Title of Invention:
PYRAZOLO[1,5-A]PYRIMIDIN-VERBINDUNG ALS TRK-KINASEHEMMER
SPC Number:
LUC00150

Dates

Filing date:
21/10/2009
Grant date:
28/02/2018
EP Publication Date:
21/12/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2018
EP B1 Publication Date:
28/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
22/01/2020
Lapsed date:
Expiration date:
21/10/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/01/2020
 
 

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

Agent

Name:
ARONOVA S.A.
From:
25/05/2018
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
HAAS, Julia
Address:
United States (US)

2

Name:
JIANG, Yutong
Address:
United States (US)

3

Name:
ZHANG, Gan
Address:
United States (US)

4

Name:
ANDREWS, Steven, W.
Address:
United States (US)

Priority

Priority Number:
107616 P
Priority Date:
22/10/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; A61P 29/00; C07D 471/04;

Publication

European Patent Bulletin

1

Issue number:
201809
Publication date:
28/02/2018
Description:
Grant (B1)

2

Issue number:
201950
Publication date:
11/12/2019
Description:
Request for limitation Filed (Art.105a)

3

Issue number:
201952
Publication date:
25/12/2019
Description:
Request for limitation of patent allowed

4

Issue number:
202004
Publication date:
22/01/2020
Description:
Limited Patent Specification (B3)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/10/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
06/06/2018 Outgoing Correspondence 1
25/05/2018 Power Of Attorney 1